ESC 365 - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Open Access

PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Event: ESC CONGRESS 2016

Topic: Atherosclerosis

Session type: Satellite Symposium

Sponsored by Amgen Cardiovascular

Date: 30 August 2016

Time: 12:45 - 13:45

Congress Session

4 presentations in this session

Introduction - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speaker: Professor J. Kastelein (Amsterdam, NL)

PCSK9i: impacting on plaque regression?

Speaker: Professor W. Koenig (Munich, DE)

PCSK9i: new horizons in CVD prevention?

Speaker: Professor K. Ray (London, GB)

Conclusion - PCSK9i: translating LDL-C lowering into plaque regression and CV event reduction?

Speaker: Professor J. Kastelein (Amsterdam, NL)

4 speakers from this session

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

21 presentations

1 follower

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)

21 presentations

0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

59 presentations

1 follower

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

21 presentations

1 follower

This platform is supported by